FDA Plans Spring Public Meetings on CBD
Issue: Food & Drug Administration (FDA) Commissioner Scott Gottlieb has announced the agency will hold public meetings on the regulation of cannabidiol (CBD) this April. While hemp was removed from the Schedule I drug list in the 2018 Farm Bill, the cannabis derivative ingredient CBD must be approved by the FDA for use in food, […]